Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

Just open a Bet365 account today and make a deposit Make a deposit of £10-£200 and then enter the 10-digit bonus code


  • Electrochemotherapy (ECT) is an approved treatment for cutaneous and subcutaneous tumor nodules in human Oncology. This technique combines the administration of certain anticancer drugs with electroporation. Local application of the electric pulses enhances drug-delivery into cells specifically at the side of the pulse application thus allowing uptake of drugs. The procedure leads to apoptotic cell death of cancer cells and a long-lasting local control and overall patient benefit. Due to the lack of systemic toxicity, the ECT can be repeated several times without the side effects of re-irradiated tissues. ECT has then been adopted in many European countries as standard treatment of cutaneous neoplasms.

  • ECT is also used in Veterinary Oncology in dogs, cats, exotics and horses. There are centers in Brazil, France, Italy, Ireland, Slovenia, UK and USA where this treatment is available. It is used for a wide variety of tumors.

Tech Electrochemotherapy

Evvivax News

  • 10-12 Apr 2017

    10-12 Apr 2017 - EVVIVAX at the World Veterinary Vaccine Conference, Washington DC, USA Join us at t...
  • 7 Apr 2017

    7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA Dr Luigi Aurisicchio, CEO at EVVIVAX and Pre...
  • 10-12 Oct 2016

    Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting
  • 6 Sep 2016

    London, 6 September 2016:EVVIVAX has participated at the meeting "Comparative Oncology: The Next Fro...